Sep 2013 to 2000 Legal InternWealth Strategies Journal
Aug 2013 to 2000 Associate EditorU.S. Securities and Exchange Commission Washington, DC Jan 2013 to May 2013 Legal ExternSiemens Ltd. China, Legal Department
Apr 2012 to Jul 2012 Assistant CounselIntermediate People's Court of Zhangzhou City
Aug 2011 to Aug 2011 Chief Judge's AssistantYi Lian Law Aid Center
Mar 2011 to Jun 2011 Volunteer CounselConcord & Partners Law Firm
Jun 2010 to Jul 2010 Legal Intern
Education:
Georgetown University Law Center Washington, DC 2013 Master of LawsTsinghua University 2008 to 2012 Bachelor of Laws
1303 E Herndon Ave, Fresno, CA 93720 5594507790 (Phone)
Fresno Cancer Center 7887 N Cedar Ave, Fresno, CA 93720 5594371000 (Phone)
7130 N Millbrook Ave, Fresno, CA 93720 5594505500 (Phone)
Certifications:
Radiation Oncology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English Chinese Mandarin
Hospitals:
1303 E Herndon Ave, Fresno, CA 93720
7130 N Millbrook Ave, Fresno, CA 93720
Fresno Cancer Center 7887 N Cedar Ave, Fresno, CA 93720
Saint Agnes Medical Center 1303 East Herndon Avenue, Fresno, CA 93720
Education:
Medical School Beijing Medical University Graduated: 1987 Medical School Roger Wlms Med Center Graduated: 1998 Medical School University Of Penn Graduated: 2002 Medical School Roger Wlms Med Center Graduated: 1996
Dr. Li Liu, Washington DC - MD (Doctor of Medicine)
Lebanon VA Medical Center Surgical Clinic 1700 S Lincoln Ave, Lebanon, PA 17042 7172726621 (phone), 7172286118 (fax)
Education:
Medical School Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) Graduated: 1982
Procedures:
Bone Marrow Biopsy Chemotherapy
Conditions:
Anemia Iron Deficiency Anemia Non-Hodgkin's Lymphoma Breast Neoplasm, Malignant Hemolytic Anemia
Languages:
English
Description:
Dr. Liu graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Lebanon, PA and specializes in Hematology/Oncology and Internal Medicine. Dr. Liu is affiliated with Lebanon VA Medical Center.
Garfield Health Center 210 N Garfield Ave STE 203, Monterey Park, CA 91754 6263077397 (phone), 6263071807 (fax)
Education:
Medical School Hunan Med Univ, Changsha City, Hunan, China Graduated: 1985
Languages:
Chinese English Spanish Vietnamese
Description:
Dr. Liu graduated from the Hunan Med Univ, Changsha City, Hunan, China in 1985. She works in Monterey Park, CA and specializes in Internal Medicine. Dr. Liu is affiliated with Garfield Medical Center and Pacific Alliance Medical Center.
- Bethesda MD, US - North Carolina NC, US Kyle Ryan BRIMACOMBE - Bethesda MD, US Mindy Irene Emily DAVIS - Rockville MD, US Yuhong FANG - Rockville MD, US Matthew HALL - Rockville MD, US Ajit JADHAV - Chantilly VA, US Li LIU - Germantown MD, US Natalia MARTINEZ - Rockville MD, US Andrew Louis MCIVER - Durham NC, US Rajan PRAGANI - Gaithersburg MD, US Jason Matthew ROHDE - Poolesville MD, US Anton SIMEONOV - Bethesda MD, US Wei ZHAO - Rockville MD, US Min SHEN - Boyds MD, US
International Classification:
C07D 417/14 C07D 487/08 A61K 31/4995 A61K 31/496
Abstract:
A compound of Formula II or a pharmaceutically acceptable salt thereof, wherein CyN is a cyclic amine group bound via a nitrogen atom; X is C or N; Rand Rare each independently a halogen, CN, CF, CHF, CHF, a C-C10alkyl group, a C1-Calkoxy group, a di(C-Calkyl)amino; m and n are each independently 1, 2, or 3, and represents either a single bond or a double bond, wherein the racemic mixture of 3-(4-(4-chlorophenyl)thiazol-2-yl)-1-(2-ethyl-5-methoxyphenyl)-6-(2-methylprop-1-en-1-yl)-5-(piperazine-1-carbonyl)pyridin-2(1H)-one atropisomers is excluded.
- Bethesda MD, US - Chapel Hill NC, US Rajan Pragani - Gaithersburg MD, US LI Liu - Germantown MD, US Mindy Irene Emily Davis - Rockville MD, US Kyle Ryan Brimacombe - Bethesda MD, US Min Shen - Boyds MD, US Anton Simeonov - Bethesda MD, US Daniel Jason Urban - Rockville MD, US Ajit Jadhav - Chantilly VA, US Xiaodong Wang - Chapel Hill NC, US Andrew Louis McIver - Durham NC, US
Compounds of Formula I and Formula II and the pharmaceutically acceptable salts thereof are disclosed The variables A, B, Y, Z, X, X, Rand Rare disclosed herein. The compounds are useful for treating cancer disorders, especially those involving mutant IDH1 enzymes. Pharmaceutical compositions containing compounds of Formula I or Formula II and methods of treatment comprising administering compounds of Formula I and Formula II are also disclosed.
Galactokinase Inhibitors For The Treatment And Prevention Of Associated Diseases And Disorders
- Bethesda MD, US - Salt Lake City UT, US Li Liu - Germantown MD, US Cordelle D. Tanega - Rockville MD, US Min Shen - Boyds MD, US Kent Lai - Salt Lake City UT, US Manshu Tang - Salt Lake City UT, US Douglas S. Auld - Beverly MA, US
Disclosed are inhibitors of human galactokinase of formula (I) that are useful in treating or preventing a galactokinase mediated disease or disorder, e.g., galactosemia. Also disclosed are a composition comprising a pharmaceutically acceptable carrier and at least one inhibitor of the invention, and a method of treating or preventing such disease or disorder in a mammal. Formula (I).